Close Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

BioVenture

Investor type Venture Capital
Founders Jacky Chen

Overview

Unlock datapoints

Portfolio analytics

Team

Investments

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.
Total investments 55
Average round size
info
The average size of a deal this fund participated in
$22M
Portfolio companies 50
Rounds per year 6.11
Lead investments 21
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.07
Exits 3
Key employees Soon
Stages of investment
Early Stage Venture
Late Stage Venture

Areas of investment

  • Health Care
  • Medical
  • Biotechnology
  • Medical Device
  • Pharmaceutical
Summary

BioVenture appeared to be the VC, which was created in 2013. The main department of described VC is located in the Suzhou. The fund was located in Asia if to be more exact in China.

Speaking about the real fund results, this VC is 30 percentage points more often commits exit comparing to other organizations. Opposing the other organizations, this BioVenture works on 24 percentage points less the average amount of lead investments. Deals in the range of 10 - 50 millions dollars are the general things for fund. The increased amount of exits for fund were in 2018. The top activity for fund was in 2019. The fund is constantly included in 2-6 deals per year.

The fund has specific favorite in a number of founders of portfolio startups. Moreover, a startup needs to be at the age of 6-10 years to get the investment from the fund. Among the most popular portfolio startups of the fund, we may highlight inui Health, LAM Therapeutics, Innovita Biological Technology. For fund there is a match between the country of its foundation and the country of its the most frequent investments - China. Among the most successful fund investment fields, there are Health Diagnostics, Therapeutics.

The usual cause for the fund is to invest in rounds with 2-3 partakers. Despite the BioVenture, startups are often financed by Yueyin Venture Capital, Proxima Ventures Ltd, Luc De Vos. The meaningful sponsors for the fund in investment in the same round are OrbiMed, CD Capital, iGlobe Partners. In the next rounds fund is usually obtained by YuanMing Capital, Sanofi, Qiming Venture Partners.

This organization was formed by Jacky Chen.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of BioVenture:
Typical Co-investors
BioVenture is more likely to invest in rounds together with the following funds:
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after BioVenture:

Funds with similar focus

Funds from China
Funds with similar focus located in China:
Funds with the same geo focus
Funds with similar geography of portfolio companies:
Funds doing lead investments
Funds with similar focus acting as lead investors:

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Degron Therapeutics

$22M09 Jun 2022 Shanghai, Shanghai, China

Baikuirui

$7M17 Feb 2022 Shenzhen, Guangdong, China

Shengshi Technology

CAD
Mechanical Engineering
Medical
$15M05 Jan 2022 Hangzhou, Zhejiang, China

Yuanjingtaico

Biotechnology
Medical
Medical Device
$1M28 Dec 2021 Tongzhou, Beijing, China

KingstronBio

Manufacturing
Medical
Medical Device
$47M19 Nov 2021 China, Wuwei, China

Changmugu Medical

Artificial Intelligence
Health Care
$83M10 Nov 2021 Dongcheng District, Beijing, China

Comma Bio

Food and Beverage
Machinery Manufacturing
Manufacturing
Medical
Medical Device
$15M08 Nov 2021 Shenzhen, Guangdong, China

Tripod Preclinical Research Laboratories

Biopharma
Pharmaceutical
$154M05 Nov 2021 Nanjing, Jiangsu, China

Hopstem Biotech

Biotechnology
Health Care
$40M31 Oct 2021 Shangcheng District, Zhejiang, China

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent BioVenture?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!

Wait!
You can raise money with us faster

Get matched with relevant funds

Find decision makers data

Connect with investors by email

Remind me later
...and save more than 200 hours*
*-Our recommendation and outreach system saves up to 200 hours of founder time on fundraising for seed and series A+ startups
We use LinkedIn only to verify your account. We don't import or message your contacts, nor post on your behalf.
By creating an account, you agree to our Terms of Service and Privacy Policy.
Crunchbase icon

Content report

The following text will be sent to our editors: